Bleeding Academic Research Consortium

WikiDoc Resources for Bleeding Academic Research Consortium
Articles
Most recent articles on Bleeding Academic Research Consortium Most cited articles on Bleeding Academic Research Consortium Review articles on Bleeding Academic Research Consortium Articles on Bleeding Academic Research Consortium in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bleeding Academic Research Consortium Images of Bleeding Academic Research Consortium Photos of Bleeding Academic Research Consortium Podcasts & MP3s on Bleeding Academic Research Consortium Videos on Bleeding Academic Research Consortium
Evidence Based Medicine
Cochrane Collaboration on Bleeding Academic Research Consortium Bandolier on Bleeding Academic Research Consortium TRIP on Bleeding Academic Research Consortium
Clinical Trials
Ongoing Trials on Bleeding Academic Research Consortium at Clinical Trials.gov Trial results on Bleeding Academic Research Consortium Clinical Trials on Bleeding Academic Research Consortium at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bleeding Academic Research Consortium NICE Guidance on Bleeding Academic Research Consortium NHS PRODIGY Guidance FDA on Bleeding Academic Research Consortium CDC on Bleeding Academic Research Consortium
Books
Books on Bleeding Academic Research Consortium
News
Bleeding Academic Research Consortium in the news Be alerted to news on Bleeding Academic Research Consortium News trends on Bleeding Academic Research Consortium
Commentary
Blogs on Bleeding Academic Research Consortium
Definitions
Definitions of Bleeding Academic Research Consortium
Patient Resources / Community
Patient resources on Bleeding Academic Research Consortium Discussion groups on Bleeding Academic Research Consortium Patient Handouts on Bleeding Academic Research Consortium Directions to Hospitals Treating Bleeding Academic Research Consortium Risk calculators and risk factors for Bleeding Academic Research Consortium
Healthcare Provider Resources
Symptoms of Bleeding Academic Research Consortium Causes & Risk Factors for Bleeding Academic Research Consortium Diagnostic studies for Bleeding Academic Research Consortium Treatment of Bleeding Academic Research Consortium
Continuing Medical Education (CME)
CME Programs on Bleeding Academic Research Consortium
International
Bleeding Academic Research Consortium en Espanol Bleeding Academic Research Consortium en Francais
Business
Bleeding Academic Research Consortium in the Marketplace Patents on Bleeding Academic Research Consortium
Experimental / Informatics
List of terms related to Bleeding Academic Research Consortium

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

in order to harmonize and create a universal definition of bleeding, the Bleeding Academic Research Consortium (BARC) was convened.

Definitions

Bleeding Academic Research Consortium (BARC) definition for Bleeding (DONOT EDIT)

“

Type 0: no bleeding Type 1: bleeding that is not actionable and does not cause the patient to seek unscheduled performance of studies, hospitalization, or treatment by a health-care professional; may include episodes leading to self-discontinuation of medical therapy by the patient without consulting a health-care professional. Type 2: any overt, actionable sign of hemorrhage (eg, more bleeding than would be expected for a clinical circumstance, including bleeding found by imaging alone) that does not fit the criteria for type 3, 4, or 5 but does meet at least one of the following criteria: (1) requiring nonsurgical, medical intervention by a health-care professional, (2) leading to hospitalization or increased level of care, or (3) prompting evaluation Type 3 Type 3a' Overt bleeding plus hemoglobin drop of 3 to < 5 g/dL* (provided hemoglobin drop is related to bleed)Any transfusion with overt bleeding Type 3b' Overt bleeding plus hemoglobin drop ≥5 g/dL* (provided hemoglobin drop is related to bleed)Cardiac tamponade, Bleeding requiring surgical intervention for control (excludingdental/nasal/skin/hemorrhoid), Bleeding requiring intravenous vasoactive agents Type 3c' Intracranial hemorrhage (does not include microbleeds or hemorrhagic transformation, does include intraspinal), Subcategories confirmed by autopsy or imaging or lumbar puncture, Intraocular bleed compromising vision. Type 4: CABG-related bleeding, Perioperative intracranial bleeding within 48 h, Reoperation after closure of sternotomy for the purpose of controlling bleeding Transfusion of ≥ 5 U whole blood or packed red blood cells within a 48-h period, Chest tube output more than or equal to 2L within a 24-h period Type 5: fatal bleeding Type 5a' Probable fatal bleeding; no autopsy or imaging confirmation but clinically suspicious Type 5b' Definite fatal bleeding; overt bleeding or autopsy or imaging confirmation

”